Industry

home-hero-underline

Thought leaders sharing decades of industry experience through publications and research

Press Releases

Society for Clinical Research Sites Organizes Successful Conference Discussing the Need for Diversity in Clinical Trials

May 22, 2022 The drive to diversify clinical trials most definitely has intensified.  With a confluence of factors, from precision therapies needing investigational representation to …

Read More →

SCRS Puts A Spotlight On Diversity

June 9, 2022 When asked about patient diversity in clinical trials, Diana Foster likes to reflect back to 2016. Foster, VP, strategy and special projects …

Read More →

The Society for Clinical Research Sites (SCRS) First in Kind Diversity Site Solutions Summit

April 13, 2022 The Society of Clinical Research Sites (SCRS) will be hosting its inaugural Diversity Site Solutions Summit on 20 May 2022 in Austin, Texas. This …

Read More →

Total Diversity Clinical Trial Management Provides Signature Voice Sponsorship for First Site-Focused Diversity Conference in the Clinical Trials Industry

Amanda Rangel Dallas, Texas, April 12, 2022 – Total Diversity Clinical Trial Management, a global Contract Research Organization and full-service Diversity Organization, is supporting the Society …

Read More →

Industry Veteran Mark Hanley Joins Total Diversity Board of Directors

Amanda Rangel Dallas, Texas, April 28, 2022 – Total Diversity Clinical Trial Management, a global Contract Research Organization and full-service Diversity Organization, has announced Mark Hanley …

Read More →

Kim Kundert and Amanda Rangel Join Total Diversity Following the Announcement of Focused Diversity Services

Dallas, Texas, September 30, 2021 – TOTAL Diversity (TOTAL), a woman-owned full service CRO with a long-standing history of recruiting and enrolling diverse populations, has …

Read More →

Total Clinical Trial Management Announces the Launch of Total Diversity

Melynda Geurts, MS Dallas, Texas, September 28, 2021 – Total Clinical Trial Management (TCTM), a woman-owned full service CRO, has recently announced a new brand …

Read More →

Former Surgeon General Jerome Adams Announced as Chairman of the Board of Total Diversity Clinical Trial Management

Amanda Rangel Dallas, Texas, March 8, 2022 – Total Diversity Clinical Trial Management, a global Contract Research Organization and full-service Diversity Organization, has announced former …

Read More →

Kenyetta Sims Announced as Director of Diversity Training & Education of Total Diversity Clinical Trial Management

Amanda Rangel Dallas, Texas, March 15, 2022 – Total Diversity Clinical Trial Management, a global Contract Research Organization and full-service Diversity Organization, has announced Kenyetta …

Read More →

Conferences

SCRS European Site Solutions Summit

April 22, 2021 Overview of …

CLiR Clinical Research Insider Summit

June 25, 2021 The Perfect …

SCRS Global Site Solutions Summit

October 1 – 3, 2021

SCRS Asia Pac Site Solutions Summit

July 13 – 14, 2021 …

Research Articles

Diversity and Inclusion in Clinical Trials

Diana Foster, Ph.D.CEO, Total Diversity Clinical Trials Management One of the most important new areas of emphasis in the clinical trials industry today is the …

Read More →

Identify Opportunities to Improve Diversity Recruitment

Diana Foster, PhD. || While it’s important to note that there are areas where the industry can improve, there are unique opportunities of improvement for …

Read More →

The Diversity Site Assessment Tool (DSAT), Reliability and Validity of the Industry Gold Standard for Establishing Investigator Site Ranking

Diana Foster, Ph.D. Vice President, Strategy and Special Projects, Society of Clinical Research Site ABSTRACT Background: The purpose of this study was to evaluate the reliability …

Read More →

Consultative Opportunities

Dr. Diana Foster, Ph.D

An innovative leader

Diana Foster is a recognized expert in the intricacies of site management and an innovator in the use of strategic marketing and positioning tactics, her focus and strategic guidance in the area of diversity among clinical trials positions Diana as a continued thought leader related to this critical movement in the clinical trial industry.

Don't Let Site Enrollment Be
an Afterthought